IL10RA and lymphoma: Moreover, it has been reported that the IL10RA Ser138Gly variant showed a weak association with the risk of all lymphoma combined (odds ratio [OR], 0.81; 95% CI, 0.65–1.02), mainly driven by the 50% risk reduction for Hodgkin's lymphoma (HL) (Nieters et al., 2006).